Skip to main content
. 2017 May 26;8(43):74129–74138. doi: 10.18632/oncotarget.18273

Figure 2. Preoperative (Pre-op) and postoperative day 1 (POD1) thyroid stimulating hormone receptor (TSHR) mRNA expression levels in patients with papillary thyroid carcinoma (PTC) and patients with benign thyroid disease (BTD).

Figure 2

Thyroid stimulating hormone receptor (TSHR) mRNA expression levels in healthy volunteers (HV) at different times.